{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:20:38Z","timestamp":1791195638412,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":3078,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1093\/bja\/aep128","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T01:48:55Z","timestamp":1243475335000},"page":"70-81","source":"Crossref","is-referenced-by-count":58,"title":["Immunomodulation in the critically ill"],"prefix":"10.1016","volume":"103","author":[{"given":"N.R.","family":"Webster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.F.","family":"Galley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/aep128_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(05)60602-2","article-title":"Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group","volume":"351","author":"Abraham","year":"1998","journal-title":"Lancet"},{"key":"10.1093\/bja\/aep128_bib2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aep128_bib3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.1995.03520360048038","article-title":"Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group","volume":"273","author":"Abraham","year":"1995","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aep128_bib4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.CIR.0000138932.17956.F1","article-title":"Prior statin therapy is associated with a decreased rate of severe sepsis","volume":"110","author":"Almog","year":"2004","journal-title":"Circulation"},{"key":"10.1093\/bja\/aep128_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.ccx.0000176691.95562.43","article-title":"Glucocorticoids in the treatment of severe sepsis and septic shock","volume":"11","author":"Annane","year":"2005","journal-title":"Curr Opin Crit Care"},{"key":"10.1093\/bja\/aep128_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aep128_bib7","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome","volume":"342","author":"ARDSnet","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aep128_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","article-title":"How corticosteroids control inflammation: quintiles prize lecture 2005","volume":"148","author":"Barnes","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1093\/bja\/aep128_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American\u2013European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib10","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM198712173172504","article-title":"High dose corticosteroids in patients with the adult respiratory distress syndrome","volume":"317","author":"Bernard","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aep128_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aep128_bib12","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"ACCP\/SCCM consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"10.1093\/bja\/aep128_bib13","first-page":"187","article-title":"Surgical sepsis: dysregulation of immune function and therapeutic implications","volume":"1","author":"Boontham","year":"2003","journal-title":"Surg J R Coll Surg Edinb Irel"},{"key":"10.1093\/bja\/aep128_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1440-1681.2001.03425.x","article-title":"Immune-derived opioids and peripheral antinociception","volume":"28","author":"Cabot","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1093\/bja\/aep128_bib15","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00003246-199609000-00002","article-title":"INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group","volume":"24","author":"Cohen","year":"1996","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00003246-199404000-00022","article-title":"Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study","volume":"22","author":"Cowley","year":"1994","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib17","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/00003246-199508000-00019","article-title":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature","volume":"23","author":"Cronin","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock","volume":"34","author":"Dellinger","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1093\/bja\/aep128_bib19","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1097\/00003246-199422110-00005","article-title":"Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group","volume":"22","author":"Dhainaut","year":"1994","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm0697-678","article-title":"Monocyte deactivation in septic patients: restoration by IFN-gamma treatment","volume":"3","author":"Docke","year":"1997","journal-title":"Nat Med"},{"key":"10.1093\/bja\/aep128_bib21","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1016\/S0021-9258(18)99230-6","article-title":"Interleukin 1 (IL-1) receptor antagonist binds to the 80 kDa IL-1 receptor but does not initiate IL-1 signal transduction","volume":"266","author":"Dripps","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1093\/bja\/aep128_bib22","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1164\/rccm.200204-302OC","article-title":"Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis","volume":"166","author":"Eichacker","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib23","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00134-008-1266-6","article-title":"Design, conduct, analysis and reporting of a multi-national placebo controlled trial of activated protein C for persistent septic shock","volume":"34","author":"Finfer","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1093\/bja\/aep128_bib24","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199606273342603","article-title":"Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group","volume":"334","author":"Fisher","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aep128_bib25","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/jama.1994.03510470040032","article-title":"Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group","volume":"271","author":"Fisher","year":"1994","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aep128_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/CS20000073","article-title":"Effect of ciprofloxacin on the activation of the transcription factors NF\u03baB, AP-1 and NF-IL-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell line","volume":"99","author":"Galley","year":"2000","journal-title":"Clin Sci"},{"key":"10.1093\/bja\/aep128_bib27","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1213\/00000539-199806000-00030","article-title":"The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes","volume":"86","author":"Galley","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aep128_bib28","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/bja\/aen079","article-title":"Activated protein C inhibits chemotaxis and interleukin-6 release by human neutrophils without affecting other neutrophil functions","volume":"100","author":"Galley","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aep128_bib29","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/00003246-199708000-00029","article-title":"Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8 and nitrite from an endothelial cell model of sepsis","volume":"25","author":"Galley","year":"1997","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib30","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/art.23940","volume":"58","author":"Genovese","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1093\/bja\/aep128_bib31","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1097\/00003246-199311000-00029","article-title":"Free radicals and antioxidants in sepsis","volume":"21","author":"Goode","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00003246-199804000-00027","article-title":"Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage","volume":"26","author":"Heard","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1440-1843.2007.01192.x","article-title":"Comparing the protective effects of ciprofloxacin, moxifloxacin and levofloxacin in mice with lipopolysaccharide-induced acute lung injuries","volume":"13","author":"Huang","year":"2008","journal-title":"Respirology"},{"key":"10.1093\/bja\/aep128_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00540-005-0377-2","article-title":"Effects of propofol vs methohexital on neutrophil function and immune status in critically ill patients","volume":"20","author":"Huettemann","year":"2006","journal-title":"J Anesth"},{"key":"10.1093\/bja\/aep128_bib35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of blood stream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"10.1093\/bja\/aep128_bib36","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1365-2044.2004.03837.x","article-title":"Effect of propofol and isoflurane anaesthesia on the immune response to surgery","volume":"59","author":"Inada","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1093\/bja\/aep128_bib37","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1164\/ajrccm.160.4.9901075","article-title":"Corticosteroids in acute respiratory failure","volume":"160","author":"Jantz","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib38","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1074\/jbc.C100017200","article-title":"Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis","volume":"276","author":"Joyce","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1093\/bja\/aep128_bib39","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archinte.165.8.898","article-title":"Optimising the prediction of perioperative mortality in vascular surgery by using a customized probability model","volume":"165","author":"Kertai","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1093\/bja\/aep128_bib40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0167-5699(95)80161-8","article-title":"Cytokine binding proteins: stimulating antagonists","volume":"16","author":"Klein","year":"1995","journal-title":"Immunology Today"},{"key":"10.1093\/bja\/aep128_bib41","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1086\/314079","article-title":"Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients","volume":"31","author":"Kollef","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1093\/bja\/aep128_bib42","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1213\/00000539-199812000-00041","article-title":"Spinal but not general anesthesia increases the ratio of T helper 1 to T helper 2 cell subsets in patients undergoing transurethral resection of the prostate","volume":"87","author":"LeCras","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aep128_bib43","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/00003246-199507000-00021","article-title":"Steroid controversy in sepsis and septic shock: a meta-analysis","volume":"23","author":"Lefering","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib44","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.freeradbiomed.2008.09.003","article-title":"The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide\u2013peptidoglycan model of sepsis","volume":"45","author":"Lowes","year":"2008","journal-title":"Free Rad Biol Med"},{"key":"10.1093\/bja\/aep128_bib45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1164\/ajrccm\/138.1.62","article-title":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock","volume":"138","author":"Luce","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1093\/bja\/aep128_bib46","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/bja\/88.6.797","article-title":"Differential modulation of interleukin-6 and interleukin-10 by diclofenac in patients undergoing major surgery","volume":"88","author":"Mahdy","year":"2002","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aep128_bib47","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/00003246-199711000-00018","article-title":"Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma","volume":"25","author":"Martin","year":"1997","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib48","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1378\/chest.06-2100","article-title":"Methylprednisolone infusion in early severe acute respiratory distress syndrome: results of a randomised controlled trial","volume":"131","author":"Meduri","year":"2007","journal-title":"Chest"},{"key":"10.1093\/bja\/aep128_bib49","first-page":"159","article-title":"Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome","volume":"280","author":"Meduri","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aep128_bib50","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1164\/ajrccm.158.5.9801107","article-title":"Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment","volume":"158","author":"Meduri","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib51","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/ajrccm.165.7.2106014","article-title":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome","volume":"165","author":"Meduri","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-141-1-200407060-00014","article-title":"Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose","volume":"141","author":"Minneci","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1093\/bja\/aep128_bib53","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.4049\/jimmunol.158.6.2898","article-title":"IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production","volume":"158","author":"Muchamuel","year":"1997","journal-title":"J Immunol"},{"key":"10.1093\/bja\/aep128_bib54","doi-asserted-by":"crossref","first-page":"451S","DOI":"10.1378\/chest.123.5_suppl.451S","article-title":"The problems and challenges of immunotherapy in sepsis","volume":"123","author":"Nasraway","year":"2003","journal-title":"Chest"},{"key":"10.1093\/bja\/aep128_bib55","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1086\/315775","article-title":"A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia","volume":"182","author":"Nelson","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1093\/bja\/aep128_bib56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/348550a0","article-title":"Interleukin 1 receptor antagonist reduces mortality from endotoxin shock","volume":"348","author":"Ohlsson","year":"1990","journal-title":"Nature"},{"key":"10.1093\/bja\/aep128_bib57","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group","volume":"25","author":"Opal","year":"1997","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib58","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.CCM.0000108867.87890.6D","article-title":"Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial","volume":"32","author":"Opal","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib59","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4049\/jimmunol.177.3.1967","article-title":"Circulating cytokine\/inhibitor profiles reshape the understanding of the SIRS\/CARS continuum in sepsis and predict mortality","volume":"177","author":"Osuchowski","year":"2006","journal-title":"J Immunol"},{"key":"10.1093\/bja\/aep128_bib60","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI112721","article-title":"Cachectin\/tumour necrosis factor regulates hepatic acute phase gene expression","volume":"78","author":"Perlmutter","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1093\/bja\/aep128_bib61","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/bmj.39537.939039.BE","article-title":"Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis","volume":"336","author":"Peter","year":"2008","journal-title":"Br Med J"},{"key":"10.1093\/bja\/aep128_bib62","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1097\/00003246-200011000-00011","article-title":"Safety of granulocyte colony-stimulating factor (filgrastim) in intubated patients in the intensive care unit: interim analysis of a prospective, placebo-controlled, double-blind study","volume":"28","author":"Pettila","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib63","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1165\/rcmb.2007-0014OC","article-title":"Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1","volume":"39","author":"Quante","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1093\/bja\/aep128_bib64","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00003246-200104000-00015","article-title":"Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study","volume":"29","author":"Reinhart","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib65","doi-asserted-by":"crossref","first-page":"S342","DOI":"10.1086\/513857","article-title":"Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients","volume":"179","author":"Root","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1093\/bja\/aep128_bib66","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa050333","article-title":"Incidence and outcomes of acute lung injury","volume":"353","author":"Rubenfeld","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aep128_bib67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00000658-197609000-00011","article-title":"Steroids in the treatment of clinical septic shock","volume":"184","author":"Schumer","year":"1976","journal-title":"Ann Surg"},{"key":"10.1093\/bja\/aep128_bib68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-5728(97)00220-8","article-title":"Evidence for opioid receptors on cells involved in host defense and the immune system","volume":"83","author":"Sharp","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1093\/bja\/aep128_bib69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aep128_bib70","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome","volume":"354","author":"Steinberg","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aep128_bib71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00003246-200202000-00009","article-title":"Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients","volume":"30","author":"Stephan","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1473-3099(06)70439-X","article-title":"Statins: panacea for sepsis?","volume":"6","author":"Terblanche","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1093\/bja\/aep128_bib73","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/330662a0","article-title":"Anti-cachectin\/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia","volume":"330","author":"Tracey","year":"1987","journal-title":"Nature"},{"key":"10.1093\/bja\/aep128_bib74","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1073\/pnas.89.11.4845","article-title":"Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo","volume":"89","author":"Van Zee","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/bja\/aep128_bib75","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00003246-200003000-00006","article-title":"Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis","volume":"28","author":"Vincent","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1093\/bja\/aep128_bib76","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000058753","article-title":"Clinical aspects: from systemic inflammation to immunoparalysis","volume":"74","author":"Volk","year":"2000","journal-title":"Chem Immunol"},{"key":"10.1093\/bja\/aep128_bib77","doi-asserted-by":"crossref","first-page":"37622","DOI":"10.1074\/jbc.M301224200","article-title":"Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1093\/bja\/aep128_bib78","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1074\/jbc.M604367200","article-title":"Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1093\/bja\/aep128_bib79","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aep128_bib80","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aep128_bib81","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11481-008-9124-4","article-title":"Opioids and infections in the intensive care unit should clinicians and patients be concerned?","volume":"3","author":"Weinert","year":"2008","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1093\/bja\/aep128_bib82","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0883-9441(95)90027-6","article-title":"Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients","volume":"10","author":"Weiss","year":"1995","journal-title":"J Crit Care"},{"key":"10.1093\/bja\/aep128_bib83","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/jac\/dki251","article-title":"Differential effects of three antibiotics on T helper cell cytokine expression","volume":"56","author":"Williams","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1093\/bja\/aep128_bib84","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1378\/chest.119.2.523","article-title":"Filgrastim in patients with pneumonia and severe sepsis or septic shock","volume":"119","author":"Wunderink","year":"2001","journal-title":"Chest"},{"key":"10.1093\/bja\/aep128_bib85","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00003246-200205000-00026","article-title":"Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity","volume":"30","author":"Zedtwitz-Liebenstein","year":"2002","journal-title":"Crit Care Med"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217340436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217340436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/103\/1\/70\/1251397\/aep128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T22:49:20Z","timestamp":1710370160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217340436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0007091217340436"],"URL":"https:\/\/doi.org\/10.1093\/bja\/aep128","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}